OMC Financial Services’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-3,279
Closed -$695K – 38
2026
Q2
$695K Hold
3,279
– – 0.23% 48
2026
Q1
$643K Hold
3,279
– – 0.25% 50
2025
Q4
$569K Hold
3,279
– – 0.21% 51
2025
Q3
$625K Hold
3,279
– – 0.23% 50
2025
Q2
$589K Hold
3,279
– – 0.24% 51
2025
Q1
$555K Hold
3,279
– – 0.25% 50
2024
Q4
$495K Hold
3,279
– – 0.21% 52
2024
Q3
$449K Hold
3,279
– – 0.21% 53
2024
Q2
$449K Hold
3,279
– – 0.21% 53
2024
Q1
$436K Buy
+3,279
New +$425K 0.22% 50

Other funds holding DGX

OMC Financial Services's DGX Position: Q3 2026 in Review

OMC Financial Services sold out of Quest Diagnostics (DGX) in Q3 2026, closing a stake of 3,279 shares — an estimated $695K sold.

OMC Financial Services first reported a position in DGX in Q1 2024 and held it in 10 quarters. The position peaked at $695K in Q2 2026. 603 funds tracked by Wall St. Rank hold DGX as of Q3 2026.

  • OMC Financial Services reported no remaining Quest Diagnostics position as of Q3 2026 after selling out during the quarter.
  • OMC Financial Services sold 3,279 Quest Diagnostics shares in Q3 2026, an estimated $695K.
  • OMC Financial Services first reported a position in Quest Diagnostics in Q1 2024 and held it in 10 quarters.
  • OMC Financial Services's Quest Diagnostics position peaked at $695K in Q2 2026.
  • 603 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.

Based on OMC Financial Services's 13F filing for Q3 2026, filed 19 Oct 2026.